PRV prices soar, impacting the K-Bio industry significantly. Discover the reasons behind this surge and its implications.
Novartis India headcount shows promise as investors express enthusiasm over the Rs 1,400 cr deal.
Pediatric Antiemetic Oral Dissolving Film has completed Phase 3 trials, paving the way for a new indication marketing approval in Japan.
Sun Pharma quarterly profit shows a decline due to one-time charges affecting earnings.
Medicine price mark-ups are causing significant strain on hospitals, impacting their ability to survive and provide care.
Cancer drug price cuts are happening now, with reductions up to 70%. Find out how this impacts patients and the pharma industry.
Helus Pharma board pick raises questions about future direction and leadership.
FDA approval Teva marks a significant advancement in schizophrenia treatment with Weltruza.
Hanmi shares obesity drug approval has led to a sharp reversal. What does this mean for investors?
Life-saving cancer drugs are costing patients exorbitant prices. Discover why the government is being criticized for these inflated costs.
